These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16012198)

  • 1. Direct receptor cross-talk can mediate the modulation of excitatory and inhibitory neurotransmission by dopamine.
    Lee FJ; Wang YT; Liu F
    J Mol Neurosci; 2005; 26(2-3):245-52. PubMed ID: 16012198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interaction of neurotransmitters in specific circuits of the brain].
    Mora Teruel F
    An R Acad Nac Med (Madr); 1998; 115(3):653-7; discussion 657-8. PubMed ID: 10208018
    [No Abstract]   [Full Text] [Related]  

  • 3. Direct protein-protein coupling enables cross-talk between dopamine D5 and gamma-aminobutyric acid A receptors.
    Liu F; Wan Q; Pristupa ZB; Yu XM; Wang YT; Niznik HB
    Nature; 2000 Jan; 403(6767):274-80. PubMed ID: 10659839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spillover and synaptic cross talk mediated by glutamate and GABA in the mammalian brain.
    Kullmann DM
    Prog Brain Res; 2000; 125():339-51. PubMed ID: 11098670
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens.
    Rouillon C; Degoulet M; Chevallier K; Abraini JH; David HN
    Brain Res; 2008 Mar; 1198():44-54. PubMed ID: 18261716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of luteinizing hormone-releasing hormone and luteinizing hormone secretion by hypothalamic amino acids.
    Donoso AO; Seltzer AM; Navarro CE; Cabrera RJ; López FJ; Negro-Vilar A
    Braz J Med Biol Res; 1994 Apr; 27(4):921-32. PubMed ID: 8087094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems.
    Miczek KA; Fish EW; De Bold JF; De Almeida RM
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):434-58. PubMed ID: 12373445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of glutamate receptors and their interactions with dopamine and other neurotransmitters in the development of tardive dyskinesia: preclinical and clinical results.
    Szota AM; Scheel-Krüger J
    Behav Pharmacol; 2020 Sep; 31(6):511-523. PubMed ID: 32459694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of manganese on glutamate, dopamine and gamma-aminobutyric acid regulation.
    Fitsanakis VA; Au C; Erikson KM; Aschner M
    Neurochem Int; 2006; 48(6-7):426-33. PubMed ID: 16513220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrograde signaling at central synapses via endogenous cannabinoids.
    Kano M; Ohno-Shosaku T; Maejima T
    Mol Psychiatry; 2002; 7(3):234-5. PubMed ID: 11920149
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurotensin receptor mechanisms and its modulation of glutamate transmission in the brain: relevance for neurodegenerative diseases and their treatment.
    Antonelli T; Fuxe K; Tomasini MC; Mazzoni E; Agnati LF; Tanganelli S; Ferraro L
    Prog Neurobiol; 2007 Oct; 83(2):92-109. PubMed ID: 17673354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT receptor regulation of neurotransmitter release.
    Fink KB; Göthert M
    Pharmacol Rev; 2007 Dec; 59(4):360-417. PubMed ID: 18160701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurobiology of slow synaptic transmission.
    Greengard P
    Science; 2001 Nov; 294(5544):1024-30. PubMed ID: 11691979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABAergic control of substantia nigra dopaminergic neurons.
    Tepper JM; Lee CR
    Prog Brain Res; 2007; 160():189-208. PubMed ID: 17499115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamate-receptor-induced modulation of GABAergic synaptic transmission in the hippocampus.
    Belan PV; Kostyuk PG
    Pflugers Arch; 2002 May; 444(1-2):26-37. PubMed ID: 11976913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of astrocytes in the maintenance and modulation of glutamatergic and GABAergic neurotransmission.
    Schousboe A
    Neurochem Res; 2003 Feb; 28(2):347-52. PubMed ID: 12608708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of GABA and glutamate in the horizontal limb of diagonal band of Broca (hDB): role in cardiovascular responses.
    Hatam M; Nasimi A
    Brain Res; 2005 Apr; 1042(1):37-43. PubMed ID: 15823251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamate and GABA in the balance: convergent pathways sustain seizures during status epilepticus.
    Naylor DE
    Epilepsia; 2010 Jul; 51 Suppl 3():106-9. PubMed ID: 20618413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glutamic acid as a universal extracellular signal].
    Yoneda Y
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2015 Aug; 35(4):81-8. PubMed ID: 26434096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of central glutamatergic neurotransmission in the pathogenesis of psychiatric and behavioral disorders.
    Wang SJ; Yang TT
    Drug News Perspect; 2005 Nov; 18(9):561-6. PubMed ID: 16421629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.